But U.S. sent medication to Africa anyway, documents show
Weeks before President Bush announced a plan to protect African babies from AIDS, top U.S. health officials were warned that research on the key drug was flawed and may have underreported severe reactions including deaths, government documents show.It's nice to know we've got fine, ethical people working at the National Institutes of Health.
The 2002 warnings about the drug, nevirapine, were serious enough to suspend testing for more than a year, let Uganda's government know of the dangers and prompt the drug's maker to pull its request for permission to use the medicine to protect newborns in the United States.
But the National Institutes of Health, the government's premier health research agency, chose not to inform the White House as it scrambled to keep its experts' concerns from scuttling the use of nevirapine in Africa as a cheap solution, according to documents obtained by The Associated Press.
Jesus.
Also, isn't it nice how drugs with potential side effects are okay for Africa, but not for the US? Nice little double standard there.
[T]he German-owned company [Boehringer Ingelheim] no longer is seeking FDA permission to use nevirapine for protecting U.S. infants because better treatments have emerged, [Dr. Patrick Robinson, a top Boehringer AIDS specialist,] said.I guess our babies are more important than African babies.
What a load of shit.
1 comment:
Not to say that this isn't a horrible thing, but just wait. Somehow this'll be completely Bush's fault. Because, you know, he was over in in the Iraqi prisons while overseeing the National Institute of Health.
-AJ
Post a Comment